{"SPADE_UN_16210": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16210", "Peptide Name": "peptide 12", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KKXWKKWWK", "Sequence Length": 9, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:AT84 (IC50=11.3 ± 1.2 µM); IGROV-1 (IC50=14.3 ± 5.3 µM); MCF-7  (IC50=4.6 ± 1.1 µM); MCF-7/mdr (IC50=4.9 ± 1.6 µM); HL-60/ADR (IC50=4.9 ± 3.7 µM); HL-60 (IC50=6.1 ± 3.4 µM); IGROV-1/CDDP (IC50=6.6 ± 2.7 µM); K562 (IC50=7.4 ± 0.1 µM); K562/Gleevec (IC50=7.6 ± 1.3 µM); A20 (IC50=8.3 ± 1.5 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "MRC-5:IC50=87.0 ± 15.1 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "D", "Structure Description": "Not found", "Formula": "H-16O-8", "Mass": -126, "PI": 6.11, "Net Charge": 0, "Hydrophobicity": 0, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide", "Pubmed ID": "26982623", "Reference": "J Med Chem. 2016 Apr 14;59(7)2918-27.", "Author": "Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26982623"}], "Frequent Amino Acids": "KWX", "Absent Amino Acids": "ACDEFGHILMNOPQRSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 5, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_09107", "Similarity": 1.0, "Sequence": "KKWKKWKKWKK"}, {"SPADE_ID": "SPADE_N_11935", "Similarity": 1.0, "Sequence": "WKKWWKKW"}, {"SPADE_ID": "SPADE_N_11993", "Similarity": 1.0, "Sequence": "KWKKWKWKK"}]}}}